Advertisement

PharmacoEconomics & Outcomes News

, Volume 841, Issue 1, pp 9–9 | Cite as

Cost effectiveness of carfilzomib combination therapy

Clinical study
  • 5 Downloads

Reference

  1. Agirrezabal I, et al. Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data. European Journal of Health Economics : 31 Oct 2019. Available from: URL: https://doi.org/10.1007/s10198-019-01122-6

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations